Sopharma AD (SPH) — Cash Flow Reinvestment Rate
Sopharma AD (SPH) has a Cash Flow Reinvestment Rate of 3.58x as of December 2024, reinvesting zł194.60 Million (capex zł93.50 Million plus investments zł-101.11 Million) from operating cash flow of zł54.42 Million. Check SPH cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sopharma AD Cash Flow Reinvestment Rate (2011–2024)
Historical reinvestment intensity for Sopharma AD across 11 annual periods. Explore Sopharma AD long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Sopharma AD (2011–2024)
Year-by-year capital reinvestment analysis for Sopharma AD. For live market cap and broader valuation context, see Sopharma AD market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (PLN) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.73x | zł209.48 Million | zł76.73 Million | zł121.39 Million | ▲ +15.8% |
| 2023 | 2.36x | zł106.14 Million | zł45.03 Million | zł43.29 Million | ▲ +1140.3% |
| 2022 | 0.19x | zł23.68 Million | zł124.62 Million | zł23.22 Million | ▼ -81.7% |
| 2018 | 1.04x | zł29.48 Million | zł28.34 Million | zł27.84 Million | ▲ +67.3% |
| 2017 | 0.62x | zł24.87 Million | zł40.00 Million | zł22.53 Million | ▲ +72.7% |
| 2016 | 0.36x | zł18.23 Million | zł50.64 Million | zł18.23 Million | ▼ -66.0% |
| 2015 | 1.06x | zł22.59 Million | zł21.31 Million | zł22.59 Million | ▼ -18.0% |
| 2014 | 1.29x | zł26.07 Million | zł20.18 Million | zł26.07 Million | ▲ +2.3% |
| 2013 | 1.26x | zł36.96 Million | zł29.25 Million | zł36.96 Million | ▼ -29.9% |
| 2012 | 1.80x | zł63.43 Million | zł35.20 Million | zł63.43 Million | ▲ +69.0% |
| 2011 | 1.07x | zł40.97 Million | zł38.40 Million | zł40.97 Million | — |